Cell survival signalling in heart derived myofibroblasts induced by preconditioning and bradykinin: The role of p38 MAP kinase

Molecular and Cellular Biochemistry

Volumn 259, Issue 1-2, 2004, Pages 83-90

  Cooper, Marie ^a   Ytrehus, Kirsti ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Bradykinin; KATP channel; Myofibroblasts; P38 MAP kinase; Preconditioning; Simulated ischemia; Tyrosine kinase

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 5 HYDROXYDECANOIC ACID; ADENOSINE TRIPHOSPHATE; BRADYKININ; BRADYKININ B2 RECEPTOR ANTAGONIST; FORMAZAN; GENISTEIN; GLIBENCLAMIDE; ICATIBANT; MITOGEN ACTIVATED PROTEIN KINASE P38; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; TETRAZOLIUM;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HEART INFARCTION PREVENTION; HEART MUSCLE CELL; HEART STIMULATION; LETHALITY; MYOFIBROBLAST; NEWBORN; NONHUMAN; RAT; SIGNAL TRANSDUCTION; SIMULATION; WESTERN BLOTTING;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ANTI-ARRHYTHMIA AGENTS; BRADYKININ; CELL HYPOXIA; CELL SURVIVAL; ENZYME INHIBITORS; FIBROBLASTS; GLYBURIDE; IMIDAZOLES; MYOCARDIUM; NA(+)-K(+)-EXCHANGING ATPASE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PYRIDINES; RATS; RECEPTOR, BRADYKININ B2; SIGNAL TRANSDUCTION;

EID: 1942538553     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:MCBI.0000021355.14112.ba     Document Type: Article

References (26)

1. Agocha A, Sigel AV, Eghbali-Webb M: Characterization of adult human heart fibroblasts in culture: A comparative study of growth, proliferation and collagen production in human and rabbit cardiac fibroblasts and their response to transforming growth factor-beta 1. Cell Tissue Res 288: 87-93, 1997
2. Dostal DE, Rothblum KN, Conrad KM, Cooper GR, Baker KM: Detection of angiotensin I and II in cultured rat cardiac myocytes and fibroblasts. Am J Physiol 263: C851 -C863, 1992
3. Eghbali M: Cardiac fibroblasts: Function, regulation of gene expression, and phenotypic modulation. Basic Res Cardiol 87: 183-189, 1992
4. Villarreal FJ, Bahnson T, Kim NN: Human cardiac fibroblasts and receptors for angiotensin II and bradykinin: A potential role for bradykinin in the modulation of cardiac extracellular matrix. Basic Res Cardiol 93: 4-7, 1998
5. Gallagher AM, Yu H, Printz MP: Bradykinin-induced reductions in collagen gene expression involve prostacyclin. Hypertension 32: 84-88, 1998
6. Bugge E, Ytrehus K: Bradykinin protects against infarction but does not mediate ischemic preconditioning in the isolated rat heart. J Mol Cell Cardiol 2: 2333-2341, 1996
7. Feng J, Rosenkranz ER: Bradykinin pretreatment improves ischemia tolerance of the rabbit heart by tyrosine kinase mediated pathways. Ann Thorac Surg 68: 1567-1572, 1999
8. Huang HM, Toral-Barza L, Gibson GE: Interactions between inositol phosphates and cytosolic free calcium following bradykinin stimulation in cultured human skin fibroblasts. Biochim Biophys Acta 1091: 409-416, 1991
9. Maulik N, Watanabe M, Zu YL, Huang CK, Cordis GA, Schley JA, Das DK: Ischemic preconditioning triggers the activation of MAP kinases and MAPKAP kinase 2 in rat hearts. FEBS Lett 396: 233-327, 1996
10. Nakano A, Baines CP, Kim SO, Pelech SL, Downey JM, Cohen MV, Critz SD: Ischemic preconditioning activates MAPKAPK2 in the isolated rabbit heart. Evidence for the involvement of p38 MAPK. Circ Res 86: 144-151, 2000
11. Barancik M, Htun P, Strohm C, Kilian S, Schaper W: Inhibition of the cardiac p38-MAPK pathway by SB203580 delays ischemic cell death. J Cardiovasc Pharmacol 35: 474-483, 2000
12. Auchampach JA, Grover GJ, Gross GJ: Blockade of ischaemic preconditioning in dogs by the novel ATP dependent potassium channel antagonist sodium 5-hydroxydecanoate. Cardiovasc Res 26: 1054-1062, 1992
13. Esumi K, Nishida M, Shaw D, Smith TW, Marsh JD: NADH measurements in adult rat myocytes during simulated ischemia. Am J Physiol 260: H1743-H1752, 1991
14. Gordon JM, Dusting GJ, Woodman OL, Ritchie RH: Cardioprotective action of CRF peptide urocortin against simulated ischemia in adult rat cardiomyocytes. Am J Physiol 284: H330-H336, 2003
15. Xia Z, Dickens M, Raingeaud J, Davis Rj, Greenberg ME: Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 1326-1331, 1995
16. Maulik N, Yoshida T, Engelman RM, Deaton D, Flack JE, Das DK: Ischemic preconditioning atttenuates apoptotic cell death associated with ischemia/reperfusion. Mol Cell Biochem 186: 139-145, 1998
17. Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher TF, Young PR, Lee JC: SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 364: 229-233, 1995
18. Alric C, Pecher C, Schanstra JP, Bascands JL, Girolami JP: Bradykinin-induced inhibition of cell proliferation and tyrosine kinase activity in rat mesangial cells. Int J Mol Med 5: 85-93, 2000
19. Cochrane J, Williams BT, Banerjee A, Harken AH, Burke TJ, Cairns CB, Shapiro JI: Ischemic preconditioning attenuates functional, metabolic, and morphologic injury from ischemic acute renal failure in the rat. Renal Fail 21: 135-145, 1999
20. Nilsson B, Friman S, Gustafsson BI, Delbro DS: Preconditioning protects against ischemia/reperfusion injury of the liver. J Gastrointest Surg 4: 44-49, 2000
21. Zahir KS, Syed SA, Zirk JR, Restifo RJ, Thomson JG: Ischemic preconditioning improves the survival of skin and myocutancous flaps in a rat model. Plast Reconstr Surg 102: 140-150, 1998
22. Gurke L, Mattei A, Choloupka K, Marx A, Sulter PM, Steirfi P, Harder F, Heberer M: Mechanisms of ischemic preconditioning in skeletal muscle. J Surg Res 94: 18-27, 2000
23. Tauskela JS, Chakravanthy BR, Murray CL, Wang Y, Comas T, Hogan M, Hakim A, Morley P: Evidence from cultured rat cortical neurons of differences in the mechanism of ischemic preconditioning of brain and heart. Brain Res 827: 143-151, 1999
24. Arstall MA, Zhao YZ, Hornberger L, Kennedy SP, Bucholz RA, Osathanondh R, Kelly RA: Human ventricular myocytes in vitro exhibit both early and preconditioning responses to sumulated ischemia. J Mol Cell Cardiol 30: 1019-1025, 1998
25. ATP. Basic Res Cardiol 95: 243-249, 2000
26. Hattori R, Otani H, Uchiyama T, Imamura H, Cui J, Maulik N, Cordis GA, Zhu L, Das DK: Src tyrosine kinase is the trigger but not the mediator of ischemic preconditioning. Am J Physiol 281: H1066-H1074, 2001